首页> 美国卫生研究院文献>Blood >Stress hematopoiesis reveals abnormal control of self-renewal lineage bias and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells
【2h】

Stress hematopoiesis reveals abnormal control of self-renewal lineage bias and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells

机译:应激性造血显示出Mll部分串联复制(Mll-PTD)造血干/祖细胞中自我更新谱系偏向和髓系分化的异常控制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

One mechanism for disrupting the MLL gene in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) is through partial tandem duplication (MLL-PTD); however, the mechanism by which MLL-PTD contributes to MDS and AML development and maintenance is currently unknown. Herein, we investigated hematopoietic stem/progenitor cell (HSPC) phenotypes of Mll-PTD knock-in mice. Although HSPCs (LinSca1+Kit+ (LSK)/SLAM+ and LSK) in MllPTD/WT mice are reduced in absolute number in steady state because of increased apoptosis, they have a proliferative advantage in colony replating assays, CFU-spleen assays, and competitive transplantation assays over wild-type HSPCs. The MllPTD/WT-derived phenotypic short-term (ST)–HSCs/multipotent progenitors and granulocyte/macrophage progenitors have self-renewal capability, rescuing hematopoiesis by giving rise to long-term repopulating cells in recipient mice with an unexpected myeloid differentiation blockade and lymphoid-lineage bias. However, MllPTD/WT HSPCs never develop leukemia in primary or recipient mice, suggesting that additional genetic and/or epigenetic defects are necessary for full leukemogenic transformation. Thus, the Mll-PTD aberrantly alters HSPCs, enhances self-renewal, causes lineage bias, and blocks myeloid differentiation. These findings provide a framework by which we can ascertain the underlying pathogenic role of MLL-PTD in the clonal evolution of human leukemia, which should facilitate improved therapies and patient outcomes.
机译:破坏骨髓增生异常综合征(MDS)和急性髓细胞性白血病(AML)中MLL基因的一种机制是通过部分串联复制(MLL-PTD)。但是,目前还不清楚MLL-PTD促进MDS和AML开发和维护的机制。在这里,我们调查了Mll-PTD敲入小鼠的造血干/祖细胞(HSPC)表型。尽管MPC - Sca1 + Kit + (LSK)/ SLAM + 和LSK) > PTD / WT 小鼠在稳态下由于凋亡增加而绝对数量减少,它们在菌落重铺试验,CFU-脾脏试验和竞争性移植试验中具有优于野生型HSPC的增殖优势。 Mll PTD / WT 衍生的表型短期(ST)–HSC /多能祖细胞和粒细胞/巨噬细胞祖细胞具有自我更新能力,可通过在受体中产生长期再生细胞来拯救造血功能小鼠具有意外的髓样分化阻滞和淋巴谱系偏倚。然而,Mll PTD / WT HSPC从未在原代或受体小鼠中发展出白血病,这表明对于完整的致白血病转化而言,还需要其他遗传和/或表观遗传缺陷。因此,Mll-PTD异常改变HSPC,增强自我更新,引起血统偏倚,并阻止骨髓分化。这些发现提供了一个框架,通过该框架我们可以确定MLL-PTD在人类白血病的克隆进化中的潜在致病作用,这将有助于改善治疗方法和患者预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号